Judy Illes | |
---|---|
Born | |
Nationality | Canadian |
Alma mater | Stanford University |
Scientific career | |
Fields | Neuroethics |
Institutions | Neuroethics Canada University of British Columbia |
Judy Illes, CM , PHD, FRSC, FCAHS, [1] (born April 30, 1960) is Professor of Neurology and Distinguished University Scholar in Neuroethics at the University of British Columbia. She is Director of Neuroethics Canada at UBC, and faculty in the Brain Research Centre at UBC and at the Vancouver Coastal Health Research Institute. [2] She also holds affiliate appointments in the School of Population and Public Health and the School of Journalism at UBC, and in the Department of Computer Science and Engineering at the University of Washington in Seattle, WA. USA. She was appointed a member of the Order of Canada in 2017.
Illes' research focuses on the ethical, legal, social and policy challenges specifically at the intersection of the neurosciences and biomedical ethics. This includes studies on advanced neurotechnologies in basic and clinical research, regenerative medicine, dementia, addiction, and the commercialization of cognitive neuroscience. She also leads a robust program of research and outreach devoted to improving the literacy of neuroscience and engaging stakeholders on a global scale. [3]
Illes is a pioneer of the field of neuroethics that was formally established in early 2000 to directly align biomedical ethics with neuroscience in research, clinical practice, and the commercialization of brain health. She is co-lead of the Canadian Brain Research Strategy of the International Brain Initiative, and sits on numerous advisory boards, including the Standing Committee on Ethics and the Institute for Neuroscience Mental Health and Addiction of the Canadian Institutes of Health Research. She also is a newly appointed Director-at-Large of the Canadian Academy of Health Sciences. Illes is often asked to provide expert consultation and testimony on ethics matters involving conflict of interest, neuroprivacy, and ownership of research data, governance, and regulation
In 2017, Illes was appointed to the Order of Canada. [4] [5] [6]
In philosophy and neuroscience, neuroethics is the study of both the ethics of neuroscience and the neuroscience of ethics. The ethics of neuroscience concerns the ethical, legal and social impact of neuroscience, including the ways in which neurotechnology can be used to predict or alter human behavior and "the implications of our mechanistic understanding of brain function for society... integrating neuroscientific knowledge with ethical and social thought".
Joseph J. Fins, M.D., D. Hum. Litt., M.A.C.P., F.R.C.P. is an American physician and medical ethicist. He is chief of the Division of Medical Ethics at New York Presbyterian Hospital and Weill Cornell Medical College, where he serves as The E. William Davis Jr., M.D. Professor of Medical Ethics, and Professor of Medicine, Professor of Public Health, and Professor of Medicine in Psychiatry. Fins is also Director of Medical Ethics and an attending physician at New York Presbyterian Hospital-Weill Cornell Medical Center. Fins is also a member of the adjunct faculty of Rockefeller University and has served as Associate for Medicine at The Hastings Center. He is the Solomon Center Distinguished Scholar in Medicine, Bioethics and the Law and a Visiting Professor of Law at Yale Law School. He was appointed by President Bill Clinton to The White House Commission on Complementary and Alternative Medicine Policy and currently serves on The New York State Task Force on Life and the Law by gubernatorial appointment.
UBC Hospital is a teaching hospital is
Vancouver Hospital and Health Sciences Centre (VHHSC) is an acute care hospital affiliated with the University of British Columbia and located in Vancouver, British Columbia. The VHHSC is the second largest hospital in Canada, with 1,900 beds and nearly 116,000 patients each year. VHHSC employs 9500 staff and utilizes 1000 volunteers. As of 2005, the hospital's annual budget is $463 million. It is managed by Vancouver Coastal Health.
George F. Koob is a Professor and former Chair of the Committee on the Neurobiology of Addictive Disorders at the Scripps Research Institute and Adjunct Professor of Psychology, Psychiatry, and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. In 2014 he became the director of the National Institute on Alcohol Abuse and Alcoholism.
Jonathan D. Moreno is an American philosopher and historian who specializes in the intersection of bioethics, culture, science, and national security, and has published seminal works on the history, sociology and politics of biology and medicine. He is an elected member of the National Academy of Medicine.
The National Core for Neuroethics at the University of British Columbia was established in August 2007, with support from the Canadian Institutes of Health Research, the Institute of Mental Health and Addiction, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the Canada Research Chairs program, the UBC Brain Research Centre and the UBC Institute of Mental Health. Co-founded by Judy Illes and Peter Reiner, the Core studies neuroethics, with particular focus on ethics in neurodegenerative disease and regenerative medicine, international and cross-cultural challenges in brain research, neuroimaging and ethics, the neuroethics of enhancement, and personalized medicine.
Juhn Atsushi Wada was a Japanese–Canadian neurologist known for research into epilepsy and human brain asymmetry, including his description of the Wada test for cerebral hemispheric dominance of language function. The Wada Test remains the gold standard for establishing cerebral dominance and is conducted worldwide prior to epilepsy surgery.
Paul Root Wolpe, is an American sociologist and bioethicist. He is the Raymond F. Schinazi Distinguished Research Chair in Jewish Bioethics and a professor at Emory University in Atlanta, Georgia.
Barbara Jacquelyn Sahakian, is professor of clinical neuropsychology at the department of psychiatry and Medical Research Council (MRC)/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge. She is also an honorary clinical psychologist at Addenbrooke's Hospital, Cambridge. She has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging.
The International Neuroethics Society (INS) is a professional organization that studies the social, legal, ethical, and policy implications of advances in neuroscience. Its mission is to encourage and inspire research and dialogue on the responsible use of advances in brain science. The current INS President is Joseph J. Fins, MD.
Françoise Elvina BaylisFISC is a Canadian bioethicist whose work is at the intersection of applied ethics, health policy, and practice. The focus of her research is on issues of women's health and assisted reproductive technologies, but her research and publication record also extend to such topics as research involving humans, gene editing, novel genetic technologies, public health, the role of bioethics consultants, and neuroethics. Baylis' interest in the impact of bioethics on health and public policy as well as her commitment to citizen engagement]and participatory democracy sees her engage with print, radio, television, and other online publications.
Alan Charles Evans PhD FRSC FCAHS is a Welsh-born Canadian neuroscientist who is a James McGill Professor of Neurology and Neurosurgery, Psychiatry and Biomedical Engineering, and holds the Victor Dahdaleh Chair in Neurosciences at McGill University. He is also a researcher at the McConnell Brain Imaging Centre of the Montreal Neurological Institute, Co-Director of the Ludmer Centre for Neuroinformatics and Mental Health, Director of the McGill Centre for Integrative Neuroscience, Scientific Director of the Canadian Open Neuroscience Platform, Scientific Director of McGill's Healthy Brains, Healthy Lives program and Principal Investigator of CBRAIN, an initiative aiming to integrate Canadian neuroscience data with the Compute Canada computing network. He is recognized for his research on brain mapping, and was a co-founder of both the International Consortium for Brain Mapping and the Organization for Human Brain Mapping.
Stan Kutcher is a Canadian Senator and Professor Emeritus of Psychiatry at Dalhousie University. He was appointed to the Senate of Canada on December 12, 2018.
Nita Farahany is an Iranian American author and distinguished professor and scholar on the ramifications of new technology on society, law, and ethics. She is the author of the critically acclaimed book, The Battle for Your Brain: Defending the Right to Think Freely in the Age of Neurotechnology. She currently teaches Law and philosophy at Duke University where she is the Robinson O. Everett Distinguished Professor of Law & Philosophy at Duke Law School, the founding director of the Duke Initiative for Science and Society as well as a chair of the Bioethics and Science Policy MA program. She is active on many committees, councils, and other groups within the law, emerging technology, and bioethics communities with a focus on technologies that have increasing potential to have ethical and legal issues. In 2010 she was appointed by President Obama to the Presidential Commission for the Study of Bioethical Issues.
Catharine Antonia Winstanley is a Canadian behavioural neuroscientist. She is a Full professor in the Department of Psychology and the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia. In this role, she co-created the world’s first rat casino in an animal lab experiment to model human gambling. In 2020, Winstanley was elected to the Royal Society of Canada's College of New Scholars, Artists and Scientists.
Janice Jennifer Eng is a professor in the University of British Columbia's Department of Physical Therapy and Canada Research Chair in Neurological Rehabilitation.
Amina Zoubeidi is a Canadian research scientist and prostate cancer researcher. She's a scientist at the Vancouver Coastal Health Research Institute and an associate professor in the Department of Urologic Sciences at the University of British Columbia. During her tenure at UBC, Zoubeidi and her research team developed the first drug that targets and blocks BRN2, thus stopping Neuroendocrine prostate cancer (NEPC) tumours and creating a possible treatment for the previously thought incurable disease.
Liisa Ann Margaret Galea is a Canadian neuroscientist who is a professor of psychology at the University of British Columbia. She is a member of the Centre for Brain Health and Director of the Graduate Programme in Neuroscience. Her research considers the impact of hormones on brain health and behaviour.
Kevin Eva is a professor of medical education. He is currently a faculty member at the University of British Columbia, and Editor-in-chief for the journal Medical Education.